# Perioperative Factors and Radiographic Brixia Scores’ Effect on Early Extubation After Fallot Tetralogy Surgery

**Authors:** İbrahim Akkoç, Selin Sağlam, Ezgi Direnç Yücel, Hatice Dilek Özcanoğlu, Erkut Öztürk, Ali Can Hatemi, Funda Gumus Ozcan

PMC · DOI: 10.3390/jcm15041409 · 2026-02-11

## TL;DR

This study finds that older age, valve-preserving surgery, and lower Brixia scores are linked to early extubation after Fallot tetralogy surgery.

## Contribution

The study introduces the Brixia score as a reliable tool for predicting early extubation in Fallot tetralogy surgery.

## Key findings

- Older age and valve-preserving surgery are associated with higher early extubation rates.
- Lower Brixia scores on ICU admission and postoperative day 1 predict early extubation.
- Valve-sparing repair leads to faster lung recovery compared to transannular patch repair.

## Abstract

Introduction and Objective: This study aims to evaluate the effect of perioperative factors and radiographic Brixia scores on early extubation following corrective surgery for Fallot tetralogy at a high-volume single cardiac center. Materials and Methods: A retrospective evaluation was conducted on 120 cases who underwent complete correction due to Fallot tetralogy [Median age 6 months (IQR 5–7), Median weight 6.2 kg (IQR 5.2–8 kg)]. Patient demographics, preoperative characteristics, intraoperative variables, postoperative outcomes, surgical type, surgical duration, cardiopulmonary bypass (CPB) time, cross-clamp time, and blood product volumes were retrieved from electronic medical records. P/F ratio, PaO2/FiO2, and Oxygen Index (OI) were calculated. Early extubation was defined as extubation occurring within 6 h after the completion of surgery. The Brixia score (Interstitial opacities, 1 point; interstitial predominant alveolar, 2 points; and interstitial and alveolar opacities, 3 points) was graded for both lung lobes divided into three segments, with a total score ranging from 0 to 18. The results were analyzed statistically. Results: In 60% of the cases (n = 72), valve-preserving surgery was performed, and in 40% (n = 48), a transannular patch was used. The early extubation rate was 20% (n = 24). The median duration of mechanical ventilation was 10 h (IQR, 6–15). Older age (median 8 vs. 5 months), valve-preserving surgery, lower incidence of right-to-left shunt Patent Foramen Ovale (63% vs. 84%), higher P/F ratio on ICU admission (360 vs. 220), and lower Brixia scores on ICU admission (8 vs. 11) and on postoperative day 1 (7 vs. 12) were identified as significant factors for early extubation (p < 0.05). The mortality rate in the entire patient group was 3.3%. In multivariable logistic regression analysis, older age (OR: 1.2, 95% CI: 1.1–1.9 p = 0.03), valve-sparing repair (OR: 1.7, 95% CI: 1.2–2.5, p = 0.008), and lower postoperative Brixia scores (OR:1.4 95% CI: 1.2–2.1, p = 0.02) remained independently associated with early extubation. Conclusions: The Brixia score can be used as a reliable scoring system for evaluating postoperative lung status. Pulmonary valve-preserving repair shows a profile of earlier lung parenchyma recovery compared to transannular patch repair.

## Linked entities

- **Diseases:** Fallot tetralogy (MONDO:0008542)

## Full-text entities

- **Diseases:** chronic (MESH:D002908), right ventricular outflow tract obstruction (MESH:D000092243), pulmonary hypertension (MESH:D006976), OI (MESH:D000860), PFO (MESH:D054092), cerebral abscesses (MESH:D001922), ventricular septal defect (MESH:D006345), airway irritation (MESH:D000402), pulmonary insufficiency (MESH:D011665), ventilator-associated pneumonia (MESH:D053717), Fallot Tetralogy (MESH:D013771), genetic abnormalities (MESH:D030342), intracardiac shunts (MESH:C562451), pneumonia (MESH:D011014), right ventricular hypertrophy (MESH:D017380), thromboembolic complications (MESH:D013923), arrhythmia (MESH:D001145), infiltrates (MESH:D017254), neurological diseases (MESH:D020271), ventricular dilation (MESH:C566255), Interstitial opacities (MESH:D003318), and diastolic dysfunction (MESH:D018487), CHD (MESH:D006330), pulmonary edema (MESH:D011654), cough (MESH:D003371), COVID-19 (MESH:D000086382), lung abnormalities (MESH:D008171), low cardiac output (MESH:D002303), RV hypertrophy (MESH:D006984), cyanosis (MESH:D003490), plastic bronchitis (MESH:D001991), infections (MESH:D007239), died (MESH:D003643), annular hypoplasia (MESH:D016460), critically ill (MESH:D016638), injury to (MESH:D014947), atelectasis (MESH:D001261), inflammatory (MESH:D007249)
- **Chemicals:** Remifentanil (MESH:D000077208), milrinone (MESH:D020105), sevoflurane (MESH:D000077149), sugammadex (MESH:D000077122), fentanyl (MESH:D005283), carbon dioxide (MESH:D002245), H2O (MESH:D014867), catecholamine (MESH:D002395), dexmedetomidine (MESH:D020927), Oxygen (MESH:D010100), rocuronium (MESH:D000077123), midazolam (MESH:D008874)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12941933